介质素-2/抗介质素-2复合物通过扩大CD4+ CD25+ Foxp3+ 调节性T细胞来减轻小鼠COPD模型中的炎症
Ruirui Duan1, Ke Huang1, Tao Yu2
1Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China; National Center for Respiratory Medicine, Beijing, China; State Key Laboratory of Respiratory Health and Multimorbidity, China.
International immunopharmacology
|March 19, 2024
概括
在慢性阻塞性肺病 (COPD) 的小鼠模型中,介素-2复合体 (IL-2C) 疗法增强了调控性T细胞 (Tregs),以减少肺炎. 这种方法对通过恢复免疫平衡来治疗COPD患者充满希望.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 的特点是持续的肺炎和气囊损伤.
- 调节性T细胞 (Tregs) 对于抑制炎症反应至关重要.
- 已知互白素-2/抗互白素-2复合体 (IL-2C) 可以扩大Treg种群.
研究的目的:
- 在COPD小鼠模型中研究IL-2C的治疗潜力.
- 为了确定IL-2C是否通过增加Treg数来缓解肺炎.
主要方法:
- 使用脂多糖 (LPS) 和香烟烟雾 (CS) 建立了COPD的小鼠模型.
- 用IL-2C治疗小鼠,并对其影响进行了评估.
- 使用流细胞计量量化Treg和T辅助17 (Th17) 细胞种群.
- 肺病理,炎症和细胞因子水平通过组织病理学,免疫光学和生物化学测试进行了分析.
主要成果:
- IL-2C显著增加了脏和肺部的Treg数量.
- IL-2C治疗改善了Treg/Th17平衡,并减少了促炎性细胞因子 (IL-6,TNF-α,IL-1β,CCL5,KC,MCP-1).
- 病理性肺炎,粘液分泌和免疫细胞透被IL-2C显著减少. 削减Tregs可以抵消这些好处.
结论:
- 在COPD模型中,IL-2C在减少肺炎方面表现出治疗效果.
- 该机制涉及Tregs的扩张和恢复免疫平衡.
- IL-2C代表了一种潜在的治疗策略,用于控制COPD的炎症.
相关概念视频
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
01:28Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K